Dan‐Qian Chen

5.8k total citations · 3 hit papers
64 papers, 4.5k citations indexed

About

Dan‐Qian Chen is a scholar working on Molecular Biology, Nephrology and Pharmacology. According to data from OpenAlex, Dan‐Qian Chen has authored 64 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 22 papers in Nephrology and 10 papers in Pharmacology. Recurrent topics in Dan‐Qian Chen's work include Chronic Kidney Disease and Diabetes (16 papers), Metabolomics and Mass Spectrometry Studies (10 papers) and Liver Disease Diagnosis and Treatment (6 papers). Dan‐Qian Chen is often cited by papers focused on Chronic Kidney Disease and Diabetes (16 papers), Metabolomics and Mass Spectrometry Studies (10 papers) and Liver Disease Diagnosis and Treatment (6 papers). Dan‐Qian Chen collaborates with scholars based in China and United States. Dan‐Qian Chen's co-authors include Ying‐Yong Zhao, Nosratola D. Vaziri, Ya‐Long Feng, Gang Cao, Lin Chen, Hua Chen, Yan Guo, Yanni Wang, He-He Hu and Xu Bai and has published in prestigious journals such as Nucleic Acids Research, Bioinformatics and PLoS ONE.

In The Last Decade

Dan‐Qian Chen

60 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New insights into TGF-β/Smad signaling in tissue fibrosis

2018 881 citations He-He Hu, Dan‐Qian Chen et al. Chemico-Biological Interactions profile →
Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease

2019 309 citations Dan‐Qian Chen, Lin Chen et al. profile →
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment

2018 287 citations Lin Chen, Tian Yang et al. Biomedicine & Pharmacotherapy profile →

Peers

Countries citing papers authored by Dan‐Qian Chen

Since Specialization

Citations

This map shows the geographic impact of Dan‐Qian Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan‐Qian Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan‐Qian Chen more than expected).

Fields of papers citing papers by Dan‐Qian Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan‐Qian Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan‐Qian Chen. The network helps show where Dan‐Qian Chen may publish in the future.

Co-authorship network of co-authors of Dan‐Qian Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Dan‐Qian Chen. A scholar is included among the top collaborators of Dan‐Qian Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan‐Qian Chen. Dan‐Qian Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acetylation in renal physiology and pathophysiology 2025 ·Frontiers in Pharmacology ·Jianyu Zhang, Jun Wu, (unknown), Shiyue Liu, Ping Li, Dan‐Qian Chen	0
2	New insights into SUMOylation and NEDDylation in fibrosis 2024 ·Frontiers in Pharmacology ·Han Jin, Jun Wu, (unknown), Lina Xie, Yali Tang, (unknown), Ping Li, Dan‐Qian Chen	0
3	Therapeutic potential of artemisinin and its derivatives in managing kidney diseases 2023 ·Frontiers in Pharmacology ·Qi Jin, Tong‐Tong Liu, Dan‐Qian Chen, Liping Yang, Huimin Mao, Fang Ma, Yuyang Wang, Ping Li, Yongli Zhan	13
4	Natural Products Against Renal Fibrosis via Modulation of SUMOylation 2022 ·Frontiers in Pharmacology ·Peng Liu, Jing Zhang, Yun Wang, Chen Wang, (unknown), Dan‐Qian Chen	8
5	Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease 2022 ·Frontiers in Pharmacology ·Dan‐Qian Chen, Jun Wu, Ping Li	20
6	Expression correlation attenuates within and between key signaling pathways in chronic kidney disease 2020 ·BMC Medical Genomics ·Hui Yu, Dan‐Qian Chen, (unknown), Ying‐Yong Zhao, Yan Guo	7
7	Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis 2020 ·Phytomedicine ·Dan‐Qian Chen, Yanni Wang, Nosratola D. Vaziri, Lin Chen, He-He Hu, (unknown)	41
8	Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria 2019 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Ya‐Long Feng, Hua Chen, Dan‐Qian Chen, Nosratola D. Vaziri, Wei Su, Shixing Ma, (unknown), Jiarong Mao, Xiao-Yong Yu, Li Zhang, Yan Guo, Ying‐Yong Zhao	46
9	Machine learning distilled metabolite biomarkers for early stage renal injury 2019 ·Metabolomics ·Yan Guo, Hui Yu, Dan‐Qian Chen, Ying‐Yong Zhao	19
10	Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis 2019 ·Experimental & Molecular Medicine ·Lin Chen, Dan‐Qian Chen, Jingru Liu, Jun Zhang, Nosratola D. Vaziri, Shougang Zhuang, Hua Chen, Ya‐Long Feng, Yan Guo, Ying‐Yong Zhao	90
11	New insights into TGF-β/Smad signaling in tissue fibrosis breakdown → 2018 ·Chemico-Biological Interactions ·He-He Hu, Dan‐Qian Chen, Yanni Wang, Ya‐Long Feng, Gang Cao, Nosratola D. Vaziri, Ying‐Yong Zhao	881
12	Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment breakdown → 2018 ·Biomedicine & Pharmacotherapy ·Lin Chen, Tian Yang, Dewen Lu, Hui Zhao, Ya‐Long Feng, Hua Chen, Dan‐Qian Chen, Nosratola D. Vaziri, Ying‐Yong Zhao	287
13	Natural Products as a Source for Antifibrosis Therapy 2018 ·Trends in Pharmacological Sciences ·Dan‐Qian Chen, Ya‐Long Feng, Gang Cao, Ying‐Yong Zhao	160
14	Natural products for the prevention and treatment of kidney disease 2018 ·Phytomedicine ·Dan‐Qian Chen, He-He Hu, Yanni Wang, Ya‐Long Feng, Gang Cao, Ying‐Yong Zhao	109
15	Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy 2017 ·Chemico-Biological Interactions ·Lin Chen, Dan‐Qian Chen, Ming Wang, Dan Liu, Hua Chen, Fang Dou, Nosratola D. Vaziri, Ying‐Yong Zhao	89
16	Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression 2016 ·Redox Biology ·Hua Chen, Gang Cao, Dan‐Qian Chen, Ming Wang, Nosratola D. Vaziri, Zhihao Zhang, Jiarong Mao, Xu Bai, Ying‐Yong Zhao	143
17	The link between phenotype and fatty acid metabolism in advanced chronic kidney disease 2016 ·Nephrology Dialysis Transplantation ·Dan‐Qian Chen, Hua Chen, Lin Chen, Nosratola D. Vaziri, (unknown), Xiang-Ri Li, Ying‐Yong Zhao	89
18	Diuretic and anti-diuretic activities of the ethanol and aqueous extracts of Alismatis rhizoma 2014 ·Journal of Ethnopharmacology ·Ya‐Long Feng, Hua Chen, Ting Tian, Dan‐Qian Chen, Ying‐Yong Zhao, Rui‐Chao Lin	58
19	Diuretic and anti-diuretic activities of fractions of Alismatis rhizoma 2014 ·Journal of Ethnopharmacology ·Dan‐Qian Chen, Ya‐Long Feng, Ting Tian, Hua Chen, Lu Yin, Ying‐Yong Zhao, Lin Rui-chao	64
20	Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE 2013 ·Journal of Pharmaceutical and Biomedical Analysis ·Ying‐Yong Zhao, Ping Lei, Dan‐Qian Chen, Ya‐Long Feng, Xu Bai	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact